Filter
1026
Text search:
art
drug
resistance
Featured
97
329
Language
Document type
771
103
83
28
14
11
11
4
1
Countries / Regions
60
34
33
33
26
26
24
23
21
20
20
18
16
16
16
16
14
13
13
12
12
11
11
11
10
10
10
9
8
8
7
6
6
5
5
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
430
117
28
25
19
11
8
1
Toolboxes
272
216
25
24
19
19
13
9
8
6
5
5
4
3
3
2
2
2
2
1
1
1
1
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside
...
Celebrating ten years of success 2004-2014
Technical Report
National Report
A survival guide for clinicans.
3rd edition.
Guidelines
HIV drug resistance
July 2017
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens th
...
This resource consists of technical guidelines for District Medical Officers, counselors and laboratory technicians for second-line antiretroviral therapy drugs, operational guidelines for pilot roll-out in two centres and laboratory guidelines for viral-load testing and standard operating procedure
...
EClinicalMedicine 1 (2018) 21–27
https://doi.org/10.1016/j.eclinm.2018.06.005
2589-5370/© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
EClinicalMedicine: journal homepage: https://www.jo
...
Regional action plan 2019-2023
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant
...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acq
...
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the preval
...
